Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck: Technical methodology and preliminary results

Tumori

Volumn 90, Issue 1, 2004, Pages 66-72

  Corvò, Renzo ^a,b   Foppiano, Franca ^a   Bacigalupo, Almalina ^a   Berretta, Laura ^a   Benasso, Marco ^a   Vitale, Vito ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Head and neck; Lymph node failure; Radiotherapy; Salivary gland; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLAVICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EPIDERMOLYSIS; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE; MUCOSA INFLAMMATION; OROPHARYNX CARCINOMA; PAROTID GLAND; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; TREATMENT OUTCOME; XEROSTOMIA;

EID: 2142660168     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000115     Document Type: Article

References (25)

1. Ang KK, Garden A: Radiotherapy for head and neck cancers: indications and techniques (2nd edn). Lippincott Williams & Wilkins, Philadelphia, 2002.
2. Leslie MD, Dische S: The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol, 30: 26-32, 1994.
3. Eisbruch A, Kim HM, Terrel JE: Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys, 50: 695-704, 2001.
4. Kagei K, Shirato H, Nishioka T, Arimoto T, Hashimoto S, Kaneko M, Ohmori K, Honma A, Inuyama Y, Miyasaka K: Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol, 54: 117-121, 2000.
5. O'Sullivan B, Warde P, Grice B, Goh C, Payne D, Liu FF, Waldron J, Bayley A, Irish J, Gullane P, Cummings B: The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys, 51: 332-343, 2001.
6. Marks JE, Devineni VR, Harvey J: The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol, 13: 34-39, 1992.
7. Gregoire V, Daisne JF, Bauvois C: Selection et delimitation des volumes-cibles anatomocliniques ganglionnaires dans le tumeurs de la sphere cervico-maxillo-faciale. Cancer Radiother, 5: 614-628, 2001.
8. Gregoire V, Coche E, Cosnard G: Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol, 56: 135-150, 2000.
9. Corvò R, Benasso M, Sanguineti G, Bacigalupo A, Lionetto R, Pallestrini E, Merlano M, Vitale V, Rosso R: Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Results from a phase III randomized trial. Cancer, 92: 2856-2867, 2001.
10. Robbins KT, Atkinson J, Byers R, Cohen JI, Lavertu P, Pellitteri P: The use and misuse of neck dissection for head and neck cancers. J Am Coll Surg, 193: 91-102, 2001.
11. Sanguineti G, Foppiano F, Marcenaro M, Roncallo F, Corvò R, Ameli F, Vitale V: On the delineation of the gross tumor volume and clinical target volume for head and neck squamous cell carcinomas. Tumori, 87: 152-161, 2001.
12. International Committee for Radiation Units: Prescribing, recording and reporting photon beam therapy. ICRU-Report 50. Bethesda, Md, 1993.
13. International Committee for Radiation Units: Prescribing, recording and reporting photon beam therapy. Report 62 (Supplement to Report 50). Bethesda, Md, 1999.
14. Kaneko M, Shirato H, Nishioka A: Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumors. Oral Oncol, 34: 140-146, 1998.
15. UICC: TNM classification of malignant tumors, 6th edn, Raffaello Cortina, Milan, 2002.
16. Eisbruch A, Marsh LH, Martel MK: Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys, 36: 469-480, 1996.
17. Reddy SP, Leman CR, Marks JE, Enami B: Parotid-sparing irradiation for cancer of oral cavity. Am J Clin Oncol, 24: 341-346, 2001.
18. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R: The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys, 46: 195-205, 2000.
19. Chao KSC, Ozyigit G (Eds): IMRT For Head & Neck Cancer. Dose prescription and target delineation for nodal volumes. Lippincott, Williams and Wilkins, Philadelphia, 2003.
20. Amosson C, Ten B, Van J, Uy N, Huang E, Mai WY, Frolov A, Woo S, Chiu JK, Carpenter S, Lu HH, Grant WH, Butler EB: Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the SMART (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys, 56: 136-144, 2003.
21. Palazzi M, Soatti C, Bianchi E, Alterio D, Baio A, Bocci C, Bonetta A, Feltre L, Guazzetti R, Jereczec-Fossa B, Merletti A: Guidelines for the delineation of nodal regions of the head and neck on axial computer tomography images. Tumori, 88: 355-360, 2002.
22. Nowak PJ, Wijers OB, Lagerwaard FJ, Levendag PC: A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys, 45: 33-39, 1999.
23. Jackson SM, Hay JH, Flores AD: Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiat Oncol, 51: 123-128, 1999.
24. Murthy AK, Hendrickson FR: Is contralateral neck treatment necessary in early carcinoma of the tonsil? Int J Radiat Oncol Biol Phys, 6: 91-94, 1980.
25. Maes A, Weltens C, Flamen P, Bogaerts R, Liu X, Baetens J, Hermans R, Van der Bogaert W: Preservation of parotid function with uncomplicated conformal radiotherapy. Radiat Oncol, 62: 203-211, 2002.